MIGUEL P RIVERA
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism METAIRIE, LA NPI 1104840404
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism LA BETA BIONICS, INC. All categories
General Payments — all program years on this page
$7,101.94
- Category: General Payments
- Program years: PY2018–2024
- Record count: 403
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,399.82 across 52 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,399.82 | 52 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| BETA BIONICS, INC. | $411.86 | 6 |
| DEXCOM, INC. | $196.39 | 7 |
| Lilly USA, LLC | $164.64 | 10 |
| Antares Pharma, Inc. | $99.95 | 4 |
| Xeris Pharmaceuticals, Inc. | $70.39 | 4 |
| Corcept Therapeutics | $68.99 | 3 |
| RECORDATI_RARE_DISEASES_INC. | $62.20 | 1 |
| TOLMAR, INC. | $42.24 | 2 |
| Insulet Corporation | $38.01 | 1 |
| Acerta Pharma LLC | $33.04 | 2 |
| Medtronic, Inc. | $31.70 | 2 |
| Novo Nordisk AS | $23.83 | 1 |
| Ascensia Diabetes Care US Inc. | $23.49 | 1 |
| Ascendis Pharma Inc | $22.22 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.28 | 1 |
| Astellas Pharma US Inc | $17.07 | 1 |
| Acella Pharmaceuticals, LLC | $16.92 | 1 |
| Esperion Therapeutics, Inc. | $15.12 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.04 | 1 |
| Kowa Pharmaceuticals America, Inc. | $15.03 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.41 | 1 |
By program year
Records — PY2024 (52)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.